CIK 0001635088 · Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- operating
- EIN
- 981173944
- Phone
- 441-295-5950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $85,719,562
- in 13 filings, $45.5M under 10b5-1 plans
Net −$85,719,562. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-23 | Gline Matthew CEO | Sale 10b5-1 | −1,983,257 | $11.79 | $23.4M | 17,870,543 |
| 2024-09-23 | Gline Matthew CEO | Other disposition 10b5-1 | −498,539 | $11.97 | $6.0M | 17,372,004 |
| 2024-09-23 | Gline Matthew CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,550,000 | 14,973,184 | ||
| 2024-09-20 | Kumar Rakhi Chief Accounting Officer | Shares withheld for taxes 10b5-1 | −3,087 | $11.97 | $37K | 209,322 |
| 2024-09-20 | Gline Matthew CEO | Shares withheld for taxes 10b5-1 | −10,945 | $11.97 | $131K | 18,303,800 |
| 2024-09-20 | Pulik Richard CFO | Shares withheld for taxes 10b5-1 | −2,129 | $11.97 | $25K | 283,623 |
| 2024-09-20 | Venker Eric President & COO | Shares withheld for taxes 10b5-1 | −10,945 | $11.97 | $131K | 628,415 |
| 2024-09-12 | Oren Ilan Director | Other disposition | −3,487 | $12.12 | $42K | 95,553 |
| 2024-09-12 | Epperly Melissa B, Director | Other disposition | −4,245 | $12.12 | $51K | 36,424 |
| 2024-09-12 | MOMTAZEE JAMES C Director | Other disposition | −3,056 | $12.12 | $37K | 92,434 |
Page 29 of 29 · 570 trades